See related research by Vincent *et al.*, <http://ccforum.com/content/14/1/R12>

As reported in the previous issue of *Critical Care*, Vincent and colleagues \[[@B1]\] investigated the possible increased risk of patients with insulin-treated diabetes for morbidity and mortality in the intensive care unit (ICU). Literature is conflicting at this point, with studies showing increased risk \[[@B2],[@B3]\], decreased risk \[[@B4]\], or neutral risk \[[@B5],[@B6]\]. In their analyses, Vincent and colleagues included 3,147 patients originally recruited for the Sepsis Occurrence in Acutely ill Patients (SOAP) study \[[@B7]\], including 226 (7.2%) patients with a prior diagnosis of insulin-treated diabetes. No significant differences in ICU or 28-day hospital mortality were observed between the groups, even though patients with insulin-treated diabetes were sicker at baseline, as reflected by higher Simplified Acute Physiology Score (SAPS II) and Sequential Organ Failure Assessment (SOFA) score. From a Cox proportional hazards analysis correcting for differences in patient characteristics, it appeared that patients with insulin-treated diabetes were more likely to develop renal failure, but diabetes was not an independent predictor of ICU or 28-day mortality (hazard ratio 0.78, confidence interval 0.58 to 1.07, *P*= 0.12). Patients were followed until death or hospital discharge or for 60 days. The latter mortality rates were not discussed, probably due to low numbers in the diabetes group at 60 days.

The diabetes population in the study of Vincent and colleagues consisted only of patients with a history of insulin-treated diabetes. This definition does not classify between type 1 and type 2 diabetes, and from the large type 2 diabetes population, only the insulin-treated proportion, around 25% of all type 2 diabetes patients, is captured. How this affects the conclusions is unknown. Also, the authors did not have the opportunity to collect data with respect to glucose regulation or insulin therapy, and this might have contributed to observed group differences.

Vincent and colleagues do not stand alone in their conclusions. Very recent descriptions of two large mixed ICU populations \[[@B4]\] and, more specifically, sepsis patients \[[@B6]\] also found no differences in mortality, and perhaps even less mortality, in diabetes compared with non-diabetes patients, despite larger morbidity in the former group. Larger morbidity and development of complications in diabetes can be explained by the often pre-existing organ dysfunction and pathophysiological alterations in the disease. This raises the intriguing question of how patients with diabetes manage to survive in the ICU despite an increased risk for a variety of complications such as bloodstream infections \[[@B6],[@B8]\] and renal failure \[[@B1]\], which are, at least in the non-diabetic population, independently associated with mortality \[[@B9],[@B10]\]. Remarkably, there seems to be a lower incidence of acute lung injury in patients with diabetes \[[@B11]\].

There may be two sides to the diabetes coin. There is evidence that hyperglycemia caused by critical illness is not associated with mortality in patients with diabetes \[[@B6],[@B12],[@B13]\], but on the other hand, patients with diabetes do not seem to benefit from intensive insulin therapy during their ICU stay \[[@B14]\]. This suggests that acute hyperglycemia in critical illness and hyperglycemia due to chronic diabetes are two distinct pathophysiological entities. Perhaps this is a call for an active search for preexisting diabetes since this is often undiagnosed at the time of an event leading to hospital admission.

Various mechanisms are proposed to explain the similar outcomes of patients with diabetes and those without it. Insulin may protect through anti-inflammatory effects \[[@B15]\] given that in the intensive insulin therapy era, many patients without diabetes are receiving insulin. Also, a higher body mass index may have a protective effect against ICU mortality and may also protect people with type 2 diabetes \[[@B16]\]. Adaptation to hyperglycemia might be a key mechanism. Oxidative stress, arising from inflammation and hyperglycemia, is known to cause endothelial damage through several mechanisms and is associated with poor outcome in the critically ill \[[@B17]\]. It is possible that because diabetes patients are already adapted to oxidative stress due to previous chronic exposure to hyperglycemia, the critical illness-induced oxidative stress is more harmful to non-diabetic patients because they have not yet activated cellular adaptation mechanisms.

Whatever the mechanism is, this elegant study by Vincent and colleagues contributes to the evidence that diabetes itself is not a risk factor for mortality in the ICU. Moreover, the likely higher complication and morbidity rates of patients with diabetes and different responses to hyperglycemia suggest the need for the implementation of different treatment algorithms for both groups.
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